![]() Akoya Biosciences Akoya Biosciences is a biotechnology company specializing in high-parameter tissue analysis. | Wimasis Wimasis is a company delivering image analysis solutions for biomedical, pharmaceutical, and life sciences experts to help them automate their work processes. | ![]() Image Analysis Group Image Analysis Group (IAG) is a technology company which partners with biotech and pharma companies to develop new treatments. | TC BioPharm TC Biopharm (Holdings) is a clinical-stage cell therapy company developing immunotherapy products. | |
Founding Date | Founding Date 2015 | Founding Date 2009 | Founding Date 2007 | Founding Date 2013 |
Type | Type Public | Type Subsidiary | Type Private | Type Public |
Tags | ||||
Locations | Locations Marlborough, US HQ Menlo Park, US | Locations Córdoba, ES HQ | Locations London, GB HQ London, GB Philadelphia, US | Locations Holytown, GB HQ Leiden, NL Edinburgh, GB London, GB |
Employees | Employees 33011% decrease | Employees 1 | Employees 484% decrease | Employees 41 |
Valuation ($) | Valuation ($) 143.5 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 926.7 k |
Financial | ||||
Revenue (est.) | Revenue (est.) $81.7m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $33.8m (FY, 2024) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $47.9m (FY, 2024) | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income ($55.4m) (FY, 2024) | Net income N/A | Net income N/A | Net income (£12.2m) (FY, 2024) |
Funding | ||||
Total funding raised | Total funding raised $ 83.5m | Total funding raised N/A | Total funding raised $ 5.2m | Total funding raised $ 33.2m |
Wimasis is a company delivering image analysis solutions for biomedical, pharmaceutical, and life sciences experts to help them automate their work processes.
View company
Image Analysis Group (IAG) is a technology company which partners with biotech and pharma companies to develop new treatments.
View companyTC Biopharm (Holdings) is a clinical-stage cell therapy company developing immunotherapy products.
View company